NCT04422561View on ClinicalTrials.gov

Prophylactic Ivermectin in COVID-19 Contacts

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

340

Participants

Timeline

Start Date

May 31, 2020

Primary Completion Date

July 14, 2020

Study Completion Date

July 27, 2020

Conditions
COVID
Interventions
DRUG

Ivermectin Tablets

two doses 72 hours apart

Trial Locations (1)

44519

Zagazig University, Zagazig

All Listed Sponsors
lead

Zagazig University

OTHER_GOV

NCT04422561 - Prophylactic Ivermectin in COVID-19 Contacts | Biotech Hunter | Biotech Hunter